Methylphenidate in palliative care in cancer patient: A double-blind randomised trial versus placebo;Méthylphénidate et asthénie en soins palliatifs chez le patient cancéreux: Essai multicentrique randomisé versus placebo en double aveugle

Bulletin du Cancer

Volumn 95, Issue 2, 2008, Pages 241-246

  Laval, Guillemette ^a   Paris, Adeline ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b HÔPITAL MICHALLON   (France)

Author keywords

Asthenia; Cancer; Methylphenidate; Palliative care

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE; PLACEBO;

ADULT; ADVANCED CANCER; ARTICLE; ASTHENIA; CANCER PATIENT; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPOTHESIS; MALE; MULTICENTER STUDY; OPEN STUDY; PALLIATIVE THERAPY; PSYCHIATRIST; PSYCHOLOGIST; RANDOMIZED CONTROLLED TRIAL; SOCIAL WORKER; SYMPTOM; VISUAL ANALOG SCALE;

ADULT; AGED; ASTHENIA; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; HUMANS; METHYLPHENIDATE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; PLACEBOS; TERMINAL CARE;

EID: 40349083929     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2008.0581     Document Type: Article

References (30)